Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study

BACKGROUND: Hypertension is a risk factor for cholangiocarcinoma (CCA). The effect of anti-hypertensive drugs on the prognosis of CCA is not clear. METHODS: This is a retrospective study of 102 patients (56.9% males, median age 66 years) diagnosed with CCA and hypertension concurrently and received...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiao-Xu, Li, Jian-Hui, Fang, Peng, Qu, Xiao-Fei, Liang, Li-Jian, Lai, Jia-Ming, Yin, Xiao-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478452/
https://www.ncbi.nlm.nih.gov/pubmed/37670280
http://dx.doi.org/10.1186/s12885-023-11152-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478452/
https://www.ncbi.nlm.nih.gov/pubmed/37670280
http://dx.doi.org/10.1186/s12885-023-11152-2

Ejemplares similares